|Publication number||US4603699 A|
|Application number||US 06/673,290|
|Publication date||Aug 5, 1986|
|Filing date||Nov 20, 1984|
|Priority date||Nov 20, 1984|
|Also published as||DE3575856D1, EP0183131A1, EP0183131B1|
|Publication number||06673290, 673290, US 4603699 A, US 4603699A, US-A-4603699, US4603699 A, US4603699A|
|Inventors||Jacques M. Himpens|
|Original Assignee||Himpens Jacques M|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (11), Non-Patent Citations (2), Referenced by (43), Classifications (12), Legal Events (6)|
|External Links: USPTO, USPTO Assignment, Espacenet|
1. Field of the Invention
The present invention relates to the monitoring of haemodynamic parameters. More particularly, the present invention provides an apparatus and method for monitoring patients' osmotic or oncotic pressure in situ.
2. Background of the Invention
Apparatus for measuring hydrostatic pressure in situ is well known. A catheter is commonly inserted into a central vein or into a pulmonary artery for this purpose.
However, fluid exchanges occurring between the blood stream and body tissues which produce conditions such as pulmonary edema are governed by osmotic pressure effects, particularly colloid osmotic pressure (COP), as well as hydrostatic pressure. Monitoring these exchanges in critically-ill patients and high-risk surgical patients is particularly important, but in these cases it is also very important to minimize the effect of such monitoring on the patient's physiological condition. For example, COP monitoring can be valuable in the management of shock, myocardial infarction, serious burns, malnutrition, and hepatic or renal failure cases, but the need to minimize the risk to these patients induced by such monitoring is self-evident.
Intravascular osmotic pressure can be intermittently determined by measuring molar freezing point depression or by measuring the protein content of a blood sample. However, either measurement involves time delays and repeated blood withdrawals that make such a method cumbersome and ill-suited to monitoring critically ill patients. Furthermore, measurement of freezing point depression indicates only total osmotic pressure, and the determination of COP by measurement of the protein content of blood is very sensitive to laboratory errors in protein measurement. The Landis-Pappenheimer formula on which the latter approach is based is a species-specific exponetial function of blood protein for a given body temperature:
C=total protein (grams/dl)
x, y, z=temperature-variable constants Further discussion of this method can be found in the American Physiological Society's Handbook of Physiology (Washington, D.C., 1963) Circulation Vol. 2, pp 961-1034.
Continuous extracorporeal monitoring of COP can be achieved by shunting the bloodstream through external disc or needle osmomitors. These devices are described by Weil et al in U.S. Pat. No. 4,028,931 and by Kakuichi et al in U.S. Pat. No. 4,245,495, respectively. However, the shunting of the bloodstream through external devices is cumbersome at best. For critically-ill patients this shunting often represents an unacceptable risk, particularly when blood pressure or blood volume is low for any reason.
Additionally, it has been suggested that pulmonary edema can be produced by local changes in COP that are not readily observable elsewhere in the patients' system. Thus, the location at which COP is measured has a potentially significant effect of the usefulness of the measurement. This further complicates methods of COP determination requiring either shunting of the bloodstream or repeated blood withdrawal.
An experimental single-lumen device for short-term intravascular monitoring of COP in heparinized animals was disclosed by Henson et al, Am. J. Physiol. pp H726-H729 (1983). The device consists of a single catheter lumen terminated by a closed-end semipermeable tube and by a pressure sensor, respectively. This device is not suitable for use in human subjects, nor is it suited for use in continuous monitoring of COP in situ.
Apparatus for measuring osmotic pressure in accordance with the present invention comprises multi-lumen catheter means for insertion in a patient's bloodstream. The catheter has a distal catheter port through which one or more tubes of semi-permeable material in the catheter can be exposed to the patients' bloodstream. The tubes fluidly connect a first lumen to a second lumen. Respective ends of the tube or tubes are connected to the first and second lumens in airtight, water-tight seals. The first lumen is connected to a pressure sensor adapted to measure the pressure of fluid in that lumen. While in situ the tube or tubes may be scrubbed by ultrasonically pulsing the fluid therein, or flushed by fluid from a third lumen to remove debris.
The catheter is inserted in the bloodstream and secured at a predetermined point. The equilibrium pressure of a physiologically normal solution filling said tube or tubes and said first and second lumens is then periodically measured and added to the concurrent hydrostatic pressure of the blood at that point in the blood stream to determine the intravascular colloid osmotic pressure at that point.
The nature and advantages of the present invention will be more clearly understood when the detailed description of the preferred embodiment given below is considered in conjunction with the drawings, wherein:
FIG. 1 is a cross section view of catheter means for apparatus in accordance with the present invention;
FIG. 1a is a cross section of the catheter means taken at "1a" in FIG. 1; and
FIG. 2 is a schematic diagram of apparatus in accordance with the present invention.
With reference to FIG. 1, the tip of a multiple-lumen polyvinyl chloride (PVC) catheter 10 with a diameter in the range of 18 Ga to 8 French for use in Swanz-Ganz catheter insertion apparatus is shown. The catheter has a first lumen 12 that is fluidly connected to a second lumen 14 through six hollow thread-like fibrils 16 that are 3 cm. long and have an outer diameter of 275 μm and an inner diameter of 40 μm. The ends of the fibrils 16 are sealed to each lumen, respectively, in an airtight and watertight seal 18. The fibrils 16, however, are semi-permeable cellulose acetate membrane tubes that are permeable to substances having a molecular weight of less than 30,000. Each fibril 16 is filled with nylon filaments 20, as in a Wick catheter. These nylon fibers 20 provide a desirable surface area to fluid volume relationship for the tubes, reducing the amount of fluid transferred out of the fibrils, and also provide internal support for the tubes, minimizing the distortion of the tubes produced by pressure differences acting across the membrane wall of each fibril 16.
The walls of the fibrils 16 are exposed through a catheter port 22 at the distal end of the catheter 10. The catheter port is one centimeter long. A third lumen 24 also opens externally through the port 22 so that fluid leaving the third lumen 24 washes across the fibrils 16. The catheter 10 also includes a balloon 26 near the distal tip of the catheter 10. The balloon 26 is inflated and deflated through a fourth lumen 28 for stabilizing the position of the catheter tip after its insertion in the bloodstream.
With reference now to FIG. 2, first and third lumens 12, 24 of the catheter 10 are connected to a flush solution reservoir which supplies physiologically normal saline solution to the lumens under pressure to fill and flush the lumens. The pressure of the solution is pulsed by a piezo-electric transducer at 0.5 to 12 W and 10 Khz to 20 Mhz to provide a scrubbing action in the fibrils 16, which prevents blockage and erythrocyte contamination of the surfaces of the fibrils 16 by loosening material that collects on them. The surfaces of the fibrils are also flushed with fluid from the third lumen 24 every thirty minutes to remove debris and prevent thrombic activity from blocking the port area 22.
The catheter and other tubing is selected so as to have a natural resonance frequency low enough to prevent the ultrasonic scrubbing from interfering with pressure measurements.
The first lumen 12 is connected to the supply reservoir 30 by a first T-valve 32 which alternatively connects the first lumen 12 to a first access port of the osmotic pressure transducer dome 34. The second lumen 14 is normally connected by a second T-valve 36 to a second access port of the first pressure transducer dome 34 or, alternately, to an air filter 38 which prevents contamination of the saline. The third lumen 24 is connected by a third T-valve 40 alternatively to the supply reservoir 30 or to the first access port of a hydrostatic pressure transducer dome 42. The second port of the hydrostatic pressure transducer dome 42 is normally closed to the air by a fourth T-valve 46, but can be opened to the air through an air filter 38.
The pressure transducer domes are each provided with a high-sensitivity (50 wv/mm H2 O) pressure transducer capsule 44. Care must be exercised to assure that the two transducers 34, 42 are at the same level and in the same horizontal plane as the catheter port 22 while monitoring a patient or calibrating the device.
With reference again to FIG. 1a, to monitor the intravascular colloidal osmotic (oncotic) pressure affecting lung tissue in accordance with the present invention, the apparatus is filled with saline and calibrated. Then the catheter 10 is inserted into a pulmonary artery and the flotation balloon 26 near the tip with the catheter is inflated. The buoyancy of the balloon 26 moves the balloon 26 and the catheter 10 toward a wall of the artery. Contact with a wall of the artery helps to maintain a stable relation between the catheter port 22 at the distal end of the catheter 10 and the bloodstream in the artery.
The pressure transducers are calibrated before the catheter is inserted by submerging the catheter port 22 in a 25% of colloidal suspension of human albumin. The apparatus is filled, and flushed with physiologically normal saline to remove any trapped air from the system. After three minutes' submersion in the albumin suspension the transducers 44 are calibrated as follows:
1. The transducers 44 are zeroed;
2. The pressure transducer domes 34, 42 are opened to ambient air pressure through T-valves 36 and 46;
3. An offset value (A1) is read from each transducer 44 and recorded; and
4. The T-valves are then adjusted so that the pressure transducer domes 34, 42 are connected only to the lumens 12, 14, and 24.
About five minutes after the catheter has been secured in place in the pulmonary artery, the fluid has reached an equilibrium such that monitoring can begin. Thereafter while the catheter 10 remains in place the readings Ah of the hydrostatic pressure transducer 42 and Ao of the osmotic pressure transducer are subtracted from the A1 value recorded for these transducers, respectively, to determine the pressure P on each transducer, which is generally stated as:
The intravascular COP value is then:
COPv =Po +Ph
The two-ended osmometer lumen in accordance with the present invention permits flushing of a sterilized catheter, to remove trapped air immediately before insertion of the catheter, which eliminates the need to store sterilized catheters in a humidity saturated environment. This osmometer also is adapted for percutaneous insertion, without the use of cut down insertion methods required by other osmometers. Furthermore, the use of multiple, fiber-filled lumens in the preferred embodiment greatly increases the ratio surface area relative to fluid volume. This increase reduces equilibration time, thereby making the use of longer catheters possible and permitting more convenient insertion.
The embodiment described above is one example of apparatus in accordance with the present invention and many variations and modifications are possible within the spirit and scope of this invention. For example, hydrostatic pressure Ph may be determined by separate means and then normalized in order to determine COPv in accordance with the present invention, or the catheter port may be located along the length of the catheter at a point away from the tip of the catheter. Also, if the pressure indicator provides negative as well as positive readings there is no need for immersing the catheter in an albumin solution for the zeroing procedure. The pressure transducers 44 can then be zeroed immediately by opening the pressure transducer domes 34 and 42 to air. In the equation, the offset value A' becomes equal to zero and P=-A. In such a case the COP becomes then:
Furthermore, one or more fibrils of polysulfane or polyacrylonitrile copolymers or a specially treated cellulose acetate may be used in place of the six fibrils described above.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2840069 *||Sep 22, 1955||Jun 24, 1958||Nat Res Dev||Penetrating instruments such as hypodermic needles and their use in an imbibition pressure meter|
|US3635075 *||Jun 29, 1970||Jan 18, 1972||Beckman Instruments Inc||Osmometer|
|US4028931 *||Feb 13, 1976||Jun 14, 1977||Cardio Pulminary Laboratory Research Foundation||Osmotic pressure sensing head|
|US4150564 *||Apr 10, 1978||Apr 24, 1979||Wescor, Inc.||Osmometer for colloid osmometry|
|US4170895 *||Feb 27, 1978||Oct 16, 1979||Kliger Gilbert L||Oncotic pressure measurement cell|
|US4245495 *||Sep 15, 1978||Jan 20, 1981||Hokkaido University||Needle-type colloid osmometer|
|US4305823 *||Jul 25, 1980||Dec 15, 1981||Ciba-Geigy Corporation||Semipermeable membranes from modified polymers|
|US4403984 *||Dec 22, 1980||Sep 13, 1983||Biotek, Inc.||System for demand-based adminstration of insulin|
|US4431009 *||Sep 8, 1981||Feb 14, 1984||Biomedical Dynamics Corporation||Apparatus for measuring blood pressure|
|US4475556 *||Jan 3, 1983||Oct 9, 1984||Reiff Theodore R||Rapid measurement of colloid osmotic equilibrium pressure|
|US4538616 *||Jul 25, 1983||Sep 3, 1985||Robert Rogoff||Blood sugar level sensing and monitoring transducer|
|1||*||An Intravascular Protein Osmometer, by John W. Henson and Robert A. Brace, American Journal of Physiology, 244 (Heart Circ. Physiol., 13): H726 H729, 1983.|
|2||An Intravascular Protein Osmometer, by John W. Henson and Robert A. Brace, American Journal of Physiology, 244 (Heart Circ. Physiol., 13): H726-H729, 1983.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4966161 *||Mar 31, 1989||Oct 30, 1990||Utah Medical Products||Apparatus for continuously measuring intracompartmental pressure within a body cavity|
|US5037386 *||Nov 17, 1989||Aug 6, 1991||Minnesota Mining And Manufacturing Company||Pressure sensing scope cannula|
|US5063936 *||Mar 23, 1990||Nov 12, 1991||Nihon Kohden Corporation||Internal pressure measuring device using catheter with multiple lumens|
|US5085223 *||Jul 28, 1989||Feb 4, 1992||Radi Medical Systems Ab||Miniaturized pressure sensor having means for protection of diaphragm|
|US5108364 *||Feb 15, 1990||Apr 28, 1992||Sumitomo Bakelte Company Limited||Monitoring catheter for medical use|
|US5133358 *||Sep 7, 1990||Jul 28, 1992||Becton, Dickinson And Company||Apparatus for rezeroing an in vivo pressure sensor and method for rezeroing|
|US5143080 *||Jun 18, 1991||Sep 1, 1992||York Kenneth K||In vivo osmometer|
|US5181516 *||Aug 1, 1991||Jan 26, 1993||Nihon Kohden Corporation||Internal pressure measuring device using catheter with multiple lumens|
|US5203340 *||Mar 16, 1992||Apr 20, 1993||Becton, Dickinson And Company||Apparatus for rezeroing an in vivo pressure sensor and method for rezeroing|
|US5723769 *||Nov 18, 1994||Mar 3, 1998||Commonwealth Scientific And Industrial Research Organisation||Diffusion cell|
|US6468262 *||Dec 2, 1999||Oct 22, 2002||Embol-X, Inc.||Buoyant tip aspiration catheter and methods of use|
|US7017394||Mar 25, 2003||Mar 28, 2006||The Regents Of The University Of California||Tear film osmometry|
|US7574902||Feb 21, 2006||Aug 18, 2009||The Regents Of The University Of California||Tear film osmometry|
|US7637885 *||Mar 29, 2005||Dec 29, 2009||Siemens Aktiengesellschaft||Catheter device for applying a medical cutting balloon intervention|
|US7905134||Apr 16, 2008||Mar 15, 2011||The Regents Of The University Of California||Biomarker normalization|
|US7987702||May 4, 2009||Aug 2, 2011||The Regents Of The University Of California||Tear film osmometry|
|US8020433||Mar 28, 2008||Sep 20, 2011||Tearlab Research, Inc.||Systems and methods for a sample fluid collection device|
|US8211053||Dec 19, 2008||Jul 3, 2012||Equilibrate, Llc||Interosmolar fluid removal|
|US8308630||Aug 4, 2010||Nov 13, 2012||Allergan, Inc.||Hydraulic gastric band with collapsible reservoir|
|US8323180||Jul 15, 2011||Dec 4, 2012||Allergan, Inc.||Hydraulic gastric band with collapsible reservoir|
|US8627712||Mar 13, 2013||Jan 14, 2014||Tearlab Research, Inc.||Systems and methods for collecting tear film and measuring tear film osmolarity|
|US8628731||Nov 17, 2011||Jan 14, 2014||Tearlab Research, Inc.||Systems and methods for collecting tear film and measuring tear film osmolarity|
|US8713997||Sep 1, 2010||May 6, 2014||Tearlab Research, Inc.||Systems and methods for collecting tear film and measuring tear film osmolarity|
|US8725435||Apr 13, 2011||May 13, 2014||Apollo Endosurgery, Inc.||Syringe-based leak detection system|
|US8840541||Feb 25, 2010||Sep 23, 2014||Apollo Endosurgery, Inc.||Pressure sensing gastric banding system|
|US8900118||May 15, 2013||Dec 2, 2014||Apollo Endosurgery, Inc.||Dome and screw valves for remotely adjustable gastric banding systems|
|US8905915||Jul 18, 2011||Dec 9, 2014||Apollo Endosurgery, Inc.||Self-regulating gastric band with pressure data processing|
|US8939888||May 5, 2011||Jan 27, 2015||Apollo Endosurgery, Inc.||Method and system for determining the pressure of a fluid in a syringe, an access port, a catheter, and a gastric band|
|US9192501||Nov 8, 2013||Nov 24, 2015||Apollo Endosurgery, Inc.||Remotely powered remotely adjustable gastric band system|
|US9217701||Feb 18, 2011||Dec 22, 2015||The Regents Of The University Of California||Biomarker normalization|
|US9217702||Nov 17, 2011||Dec 22, 2015||The Regents Of The University Of California||Biomarker normalization|
|US9335243||Sep 11, 2015||May 10, 2016||Tearlab Research, Inc.||Systems and methods for collecting tear film and measuring tear film osmolarity|
|US20030088208 *||Oct 22, 2002||May 8, 2003||Embol-X, Inc.||Buoyant tip aspiration catheter and methods of use|
|US20040036485 *||Mar 25, 2003||Feb 26, 2004||Sullivan Benjamin D.||Tear film osmometry|
|US20050154272 *||Jan 21, 2003||Jul 14, 2005||Danfoss A/S||Method and device for monitoring analyte concentration by use of differential osmotic pressure measurement|
|US20050222594 *||Mar 29, 2005||Oct 6, 2005||Siemens Aktiengesellschaft||Catheter device for applying a medical cutting balloon intervention|
|US20060137435 *||Feb 21, 2006||Jun 29, 2006||The Regents Of The University Of California||Tear film osmometry|
|US20080264151 *||Mar 28, 2008||Oct 30, 2008||Ocusense, Inc.||Systems and methods for a sample fluid collection device|
|US20080264152 *||Apr 16, 2008||Oct 30, 2008||The Regents Of The University Of California||Biomarker normalization|
|US20090241647 *||May 4, 2009||Oct 1, 2009||The Regents Of The University Of California||Tear Film Osmometry|
|US20090287178 *||Dec 19, 2008||Nov 19, 2009||Herbert Curtis B||Interosmolar fluid removal|
|US20110011166 *||Sep 1, 2010||Jan 20, 2011||Tearlab Research, Inc.||Systems and methods for collecting tear film and measuring tear film osmolarity|
|US20110144919 *||Feb 18, 2011||Jun 16, 2011||The Regents Of The University Of California||Biomarker normalization|
|U.S. Classification||600/486, 600/556, 600/368, 73/64.47|
|International Classification||A61B5/145, A61M25/00, A61B5/0215, G01N33/49, A61B5/15|
|Cooperative Classification||A61M2025/0002, A61B5/0215|
|Nov 4, 1986||CC||Certificate of correction|
|Feb 5, 1990||FPAY||Fee payment|
Year of fee payment: 4
|Jan 14, 1994||FPAY||Fee payment|
Year of fee payment: 8
|Feb 24, 1998||REMI||Maintenance fee reminder mailed|
|Aug 2, 1998||LAPS||Lapse for failure to pay maintenance fees|
|Oct 13, 1998||FP||Expired due to failure to pay maintenance fee|
Effective date: 19980805